Lorem ipsum dolor sit amet, consectet eiusmod tempor incididunt ut labore e rem ipsum dolor sit amet. sum dolor sit amet, consectet eiusmod.
| Mon - Fri: | 8:00 am - 8:00 pm |
| Saturday: | 9:00 am - 6:00 pm |
| Sunday: | 9:00 am - 6:00 pm |






Advanced Radiopharmaceutical Treatment for Cancer & Functional Disorders
At Fusion PET-CT, our Nuclear Therapies programme offers cutting-edge radiopharmaceutical treatments under expert nuclear medicine specialists. Using targeted radionuclide therapy and theranostics, we deliver precise, personalized treatment for oncology, endocrine disorders and bone-metastasis pain relief. Our advanced infrastructure ensures patient safety, fast turnaround and measurable outcomes.

Nuclear therapies—also known as radiopharmaceutical therapy, radionuclide therapy or targeted molecular therapy—use radioactive compounds that seek and destroy diseased cells while sparing healthy tissue. These treatments tap into the power of precision medicine: the same tracer used for diagnosis can guide therapy in what’s called theranostics.
We provide a comprehensive suite of specialist treatments:
Each treatment is administered under a multidisciplinary team of nuclear medicine physicians, oncologists and medical physicists, ensuring safety and efficacy.
You may be a candidate if you:
Have a confirmed thyroid carcinoma or functional thyroid disorder.
Have neuroendocrine tumours (NETs) requiring advanced targeted therapy.
Suffer from bone metastases causing significant pain.
Require personalised, molecular-guided therapy beyond conventional radiation or chemotherapy.
Seek minimally invasive, outpatient-friendly targeted treatment with measurable outcomes.
Radiopharmaceutical therapies are safe when performed by experienced teams. Common protocols include avoiding pregnancy and breastfeeding during and after therapy, and following specific instructions on medication and hydration. Radiation exposure to the general public is minimal and controlled according to international guidelines.
Costs vary depending on the type of radiopharmaceutical used, hospital stay required and insurance coverage. We provide transparent estimates and assist with documentation for third-party payers. Contact our team now for availability and to book your consultation.
Take the next step in advanced targeted molecular treatment.
Call us today or fill in the booking form to schedule your personalised assessment and start your treatment plan with the specialists at Fusion PET-CT.